Image For Activity Cover
Injectable Extended-Release Buprenorphine Treatment in the Fentanyl Era
Extended-release injectable buprenorphine products are becoming available commercially; however there is minimal clinical experience with using these products in patients with opioid use disorder. It is essential for healthcare professionals to understand and be aware of new treatment modalities for OUD to share with patients as part of treatment options. Opioids remain the leading cause of fatal overdose in the US, and highly potent synthetic opioids are the most common opioid responsible for fatal overdoses, the rate of which continues to increase. This webinar will present data on the current state of opioid use disorder in the US, review injectable extended release buprenorphine products as well as the use of extended-release buprenorphine products for patients using fentanyl, and discuss the possible role for these treatments.
Target Audience
Physicians, clinical nurse specialists, nurses (LPN/RN), nurse practitioners or other advanced practice nurses, PAs and healthcare teams.
John Mariani, MD, Associate Professor of Clinical Psychiatry, Columbia University Medical Center, New York, NY
Credit Designations Available
AMA PRA Category 1 Credit™, Nursing Contact Hours, AAPA Category 1 CME credit, and Interprofessional Continuing Education (IPCE) credit
Core Competencies as a result of participating in this activity
Compassionate, appropriate, and effective patient care
Medical Knowledge
Practice-based learning and improvement
Systems-based practice
Educational Objectives
Review the data supporting the use of injectable extended-release buprenorphine treatment for opioid use disorder.
Identify special risks that fentanyl use presents and the possible role of injectable extended release buprenorphine treatment.
Discuss the role of extended-release injectable buprenorphine in the treatment of OUD patients using fentanyl.
Method of participating in the learning process
In order to receive maximum credit, learners must:

1. Review the materials provided in this module.
2. Complete knowledge-based assessment questions to assess both prior knowledge and knowledge change following the activity
3. Complete an evaluation to assess satisfaction and plans for individual and/or team practice change.
4. Follow instructions at the end of the course regarding how to retrieve a certificate.*

*Credit will not be awarded unless all components of the program are completed. Partial credit will not be awarded.
Availability: On-Demand
Expires on 05/27/2023
Cost: FREE
Credit Offered:
1 CME Credit
1 PA-CME Credit
1 Other Professionals Credit
1 Nursing Credit
1 IPCE Credit
The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.

Funding for this initiative was made possible (in part) by grant nos. 6H79TI081968 and 1H79TI083343 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

For Buprenorphine Training Inquiries, email PCSS.


Powered By